Notch-1 Inhibition by Withaferin-A: A Therapeutic Target against Colon Carcinogenesis
Open Access
- 1 January 2010
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 9 (1), 202-210
- https://doi.org/10.1158/1535-7163.mct-09-0771
Abstract
Notch signaling plays a crucial role in the development of colon cancer; targeting the Notch pathway may sensitize colon cancers to various adjuvant agents. The focus of our current study is to identify natural compounds that target Notch signaling and that might be beneficial for the prevention and treatment of colon cancer. Withaferin-A (WA) is a bioactive compound derived from Withania somnifera, which inhibits Notch-1 signaling and downregulates prosurvival pathways, such as Akt/NF-κB/Bcl-2, in three colon cancer cell lines (HCT-116, SW-480, and SW-620). In addition, WA downregulated the expression of mammalian target of rapamycin signaling components, pS6K and p4E-BP1, and activated c-Jun-NH2-kinase–mediated apoptosis in colon cancer cells. We also established the molecular link between Notch/Akt/mammalian target of rapamycin signaling by complementary approaches (i.e., overexpression of Notch-1 or inhibition of Notch-1 by small interfering RNA). Our results suggest that WA inhibits Notch-mediated prosurvival signaling, which facilitates c-Jun-NH2-kinase–mediated apoptosis in colon cancer cell lines. These results underscore the anticancer activity of WA, which exhibits potential for further development for targeted chemotherapy and/or chemoprevention strategies in the context of colon cancer. Mol Cancer Ther; 9(1); 202–210Keywords
This publication has 57 references indexed in Scilit:
- Targeting the Notch1 and mTOR pathways in a mouse T-ALL modelBlood, 2009
- Akt-dependent and -independent mechanisms of mTOR regulation in cancerCellular Signalling, 2009
- Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancerProceedings of the National Academy of Sciences of the United States of America, 2009
- Akt-dependent NF-κB activation is required for bile acids to rescue colon cancer cells from stress-induced apoptosisExperimental Cell Research, 2009
- Identification of a potent herbal molecule for the treatment of breast cancerBMC Cancer, 2009
- γ-Secretase Inhibitors Abrogate Oxaliplatin-Induced Activation of the Notch-1 Signaling Pathway in Colon Cancer Cells Resulting in Enhanced ChemosensitivityCancer Research, 2009
- PTEN and rapamycin inhibiting the growth of K562 cells through regulating mTOR signaling pathwayJournal of Experimental & Clinical Cancer Research, 2008
- Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasisProceedings of the National Academy of Sciences of the United States of America, 2008
- Withaferin A Causes FOXO3a- and Bim-Dependent Apoptosis and Inhibits Growth of Human Breast Cancer Cells In vivoCancer Research, 2008
- Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemiaBlood, 2007